CORRESP Filing
Medicus Pharma Ltd.
Date: Dec. 2, 2025 · CIK: 0001997296 · Accession: 0001062993-25-017143
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291651
Letter
Medicus Pharma Ltd.: CORRESP - Filed by newsfilecorp.com
Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200 Conshohocken, PA 19428 December 2, 2025 VIA EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Medicus Pharma Ltd. Registration Statement on Form S-1 (No. 333-291651) Filed November 19, 2025 Dear Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, we hereby request that the effective date of the Registration Statement on Form S-1, File No. 333-291651, as amended (the " Registration Statement "), relating to the registration of up to 2,680,000 common shares of Medicus Pharma Ltd. (the "Company") be accelerated to December 4, 2025 at 5:00 PM ET or as soon thereafter as may be practicable. Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. *****
Very truly yours, By: /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm Medicus Pharma Ltd.: CORRESP - Filed by newsfilecorp.com Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200 Conshohocken, PA 19428 December 2, 2025 VIA EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Medicus Pharma Ltd. Registration Statement on Form S-1 (No. 333-291651) Filed November 19, 2025 Dear Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, we hereby request that the effective date of the Registration Statement on Form S-1, File No. 333-291651, as amended (the " Registration Statement "), relating to the registration of up to 2,680,000 common shares of Medicus Pharma Ltd. (the "Company") be accelerated to December 4, 2025 at 5:00 PM ET or as soon thereafter as may be practicable. Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. ***** Very truly yours, By: /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer